Viral load

DZIF scientists from the University of Bonn have shown that not all conventional Zika virus molecular diagnostic tests are sufficiently reliable. They developed optimised assays and a control for

In a treatment centre in Guinea, DZIF researchers from the Heinrich Pette Institute (HPI) and the Bernhard Nocht Institute (BNITM) have, for the first time, identified the human immune response in

The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine “rVSV

An international research group has identified a cellular factor of the human cell that is indispensable to the replication of Human Immunodeficiency Virus (HIV-1). Scientists of the Paul-Ehrlich

Many viral diseases tend to become chronic - including infections with the HI virus. Scientists from the DZIF site Bonn-Köln and from the TU München have now identified an immune factor which is

Infections with Zika viruses are usually harmless. However, in Brazil, reports about a potential link between an infection with the virus and brain malformations (microcephaly) in newborns have

Researchers at the Heinrich Pette Institute, Hamburg, and at the Dresden Technical University (TUD) succeeded in developing a designer enzyme that is capable of specifically removing the provirus from

The Zika virus, which is transmitted by the mosquito species Aedes aegypti, is currently spreading rapidly in South America, particularly in Brazil. The virus may damage unborn foetuses during

Virologists at the DZIF partner site Bonn-Cologne have organised the first international WHO diagnostic training workshop on MERS coronavirus in Dubai.

Since its discovery in Saudi Arabia in 2012

For the first time, scientists from the Bernard Nocht Institute for Tropical Medicine (BNITM) including DZIF researchers have, in collaboration with Swiss colleagues, confirmed a long-lasting